Africa.com

Stay Smart About Africa

Resistance to South Africa’s Vaccine Trials

Share it!

A small group of demonstrators against Africa’s first COVID-19 vaccine trial burned their face masks Wednesday as experts note a worrying level of resistance and misinformation around testing on the continent. Anti-vaccine sentiment in Africa is “the worst I’ve ever seen,” the CEO of the GAVI vaccine alliance, Seth Berkley, told an African Union vaccine conference last week. “In general, people in Africa know the diseases and want to protect each other,” he said. “In this case, the rumor mill has been dramatic.” The trial that began last week in Johannesburg is part of one already underway in Britain of the vaccine developed at the University of Oxford. Some 2,000 volunteers in South Africa are expected to take part. It’s important that vaccines be tested in Africa to see how they perform in the local context, professor of vaccinology Shabir Madhi, leader of the new COVID-19 vaccine trial in South Africa, told reporters and others in a webinar Sunday. But the demonstrators who gathered Wednesday at the University of the Witwatersrand, where the trial is based, reflect long-running fears among some in Africa over testing drugs on people who don’t understand the risks.

SOURCE: THE NEW YORK TIMES

We are committed to Africa.

Unlike many global publications, for nearly a decade we have been committed to showing a complete picture of Africa – not just a single story.  Offended by one-sided coverage of wars, disasters and disease, the founders of Africa.com created a website that provides a balanced view of Africa – current events, business, arts & culture, travel, fashion, sports, information, development, and more.

Will You Support Us?